{"id":410336,"date":"2021-01-07T08:06:39","date_gmt":"2021-01-07T13:06:39","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=410336"},"modified":"2021-01-07T08:06:39","modified_gmt":"2021-01-07T13:06:39","slug":"abiomed-continues-to-strengthen-its-intellectual-property-now-holds-more-than-1000-patents","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/abiomed-continues-to-strengthen-its-intellectual-property-now-holds-more-than-1000-patents\/","title":{"rendered":"Abiomed Continues to Strengthen its Intellectual Property, Now Holds More Than 1,000 Patents"},"content":{"rendered":"

<\/p>\n

Abiomed Continues to Strengthen its Intellectual Property, Now Holds More Than 1,000 Patents<\/b><\/p>\n

DANVERS, Mass.–(BUSINESS WIRE<\/a>)–Abiomed<\/a> (NASDAQ: ABMD) announces it has surpassed more than 1,000 patents worldwide, with more than 850 additional patents pending. Abiomed\u2019s robust intellectual property portfolio protects its current and future pump and catheter designs, along with other product components such as motors, cannulas, sensors, software, and access devices. The portfolio also protects manufacturing processes and future artificial intelligence algorithms.\n<\/p>\n

\nAbiomed is recognized as a leader in technology and innovation, with robust clinical data supporting the regulatory approvals and physician adoption of its technologies. The company employs several hundred engineers and scientists at its state-of-the-art research and development facilities in Danvers, Massachusetts, Aachen, Germany, and Berlin, Germany. Over the past 20 years, Abiomed has grown its product pipeline by investing more than $600 million in research and development.\n<\/p>\n

\n\u201cAt Abiomed, we strive to develop smaller, smarter and more connected technologies for our customers and patients,\u201d said Michael R. Minogue, Abiomed\u2019s Chairman, President and Chief Executive Officer. \u201cAbiomed will continue to innovate new technologies that address clinical challenges and help physicians recover hearts, oxygenate the body and save lives.\u201d\n<\/p>\n

ABOUT ABIOMED<\/b><\/p>\n

\nBased in Danvers, Massachusetts, USA, Abiomed, Inc. is a leading provider of medical devices that provide circulatory support and oxygenation. Our products are designed to enable the heart to rest by improving blood flow and\/or provide sufficient oxygenation to those in respiratory failure. For additional information, please visit: www.abiomed.com<\/a>.\n<\/p>\n

FORWARD-LOOKING STATEMENTS<\/b><\/p>\n

\nThis press release contains forward-looking statements. Forward-looking statements are subject to risks and uncertainties such as those described in Abiomed’s periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.\n<\/p>\n

\"\"<\/p>\n

View source version on businesswire.com: <\/span>https:\/\/www.businesswire.com\/news\/home\/20210107005146\/en\/<\/a><\/span><\/p>\n

Media Contact:<\/b><\/p>\n

\nSarah Karr
\n
Communications Manager
\n
978-882-8211
\n
skarr@abiomed.com<\/a><\/p>\n

Investor Contact:<\/b><\/p>\n

\nTodd Trapp
\n
Vice President and Chief Financial Officer
\n
(978) 646-1680
\n
ttrapp@abiomed.com<\/a><\/p>\n

KEYWORDS:<\/b> Massachusetts Germany Europe United States North America<\/p>\n

INDUSTRY KEYWORDS:<\/b> Biotechnology Medical Devices Other Health Health Cardiology<\/p>\n

MEDIA:<\/b><\/p>\n\n\n\n\n
Logo<\/b><\/font><\/td>\n<\/tr>\n
\"Logo\"<\/td>\n<\/tr>\n
<\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"

Abiomed Continues to Strengthen its Intellectual Property, Now Holds More Than 1,000 Patents DANVERS, Mass.–(BUSINESS WIRE)–Abiomed (NASDAQ: ABMD) announces it has surpassed more than 1,000 patents worldwide, with more than 850 additional patents pending. Abiomed\u2019s robust intellectual property portfolio protects its current and future pump and catheter designs, along with other product components such as motors, cannulas, sensors, software, and access devices. The portfolio also protects manufacturing processes and future artificial intelligence algorithms. Abiomed is recognized as a leader in technology and innovation, with robust clinical data supporting the regulatory approvals and physician adoption of its technologies. The company employs several hundred engineers and scientists at its state-of-the-art research and development facilities in Danvers, Massachusetts, Aachen, Germany, and Berlin, Germany. … <\/p>\n

Continue reading “Abiomed Continues to Strengthen its Intellectual Property, Now Holds More Than 1,000 Patents”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-410336","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nAbiomed Continues to Strengthen its Intellectual Property, Now Holds More Than 1,000 Patents - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/abiomed-continues-to-strengthen-its-intellectual-property-now-holds-more-than-1000-patents\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Abiomed Continues to Strengthen its Intellectual Property, Now Holds More Than 1,000 Patents - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Abiomed Continues to Strengthen its Intellectual Property, Now Holds More Than 1,000 Patents DANVERS, Mass.–(BUSINESS WIRE)–Abiomed (NASDAQ: ABMD) announces it has surpassed more than 1,000 patents worldwide, with more than 850 additional patents pending. Abiomed\u2019s robust intellectual property portfolio protects its current and future pump and catheter designs, along with other product components such as motors, cannulas, sensors, software, and access devices. The portfolio also protects manufacturing processes and future artificial intelligence algorithms. Abiomed is recognized as a leader in technology and innovation, with robust clinical data supporting the regulatory approvals and physician adoption of its technologies. The company employs several hundred engineers and scientists at its state-of-the-art research and development facilities in Danvers, Massachusetts, Aachen, Germany, and Berlin, Germany. … Continue reading "Abiomed Continues to Strengthen its Intellectual Property, Now Holds More Than 1,000 Patents"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/abiomed-continues-to-strengthen-its-intellectual-property-now-holds-more-than-1000-patents\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-01-07T13:06:39+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210107005146r1&sid=flmnd&distro=nx&lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/abiomed-continues-to-strengthen-its-intellectual-property-now-holds-more-than-1000-patents\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/abiomed-continues-to-strengthen-its-intellectual-property-now-holds-more-than-1000-patents\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Abiomed Continues to Strengthen its Intellectual Property, Now Holds More Than 1,000 Patents\",\"datePublished\":\"2021-01-07T13:06:39+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/abiomed-continues-to-strengthen-its-intellectual-property-now-holds-more-than-1000-patents\\\/\"},\"wordCount\":354,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/abiomed-continues-to-strengthen-its-intellectual-property-now-holds-more-than-1000-patents\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210107005146r1&sid=flmnd&distro=nx&lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/abiomed-continues-to-strengthen-its-intellectual-property-now-holds-more-than-1000-patents\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/abiomed-continues-to-strengthen-its-intellectual-property-now-holds-more-than-1000-patents\\\/\",\"name\":\"Abiomed Continues to Strengthen its Intellectual Property, Now Holds More Than 1,000 Patents - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/abiomed-continues-to-strengthen-its-intellectual-property-now-holds-more-than-1000-patents\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/abiomed-continues-to-strengthen-its-intellectual-property-now-holds-more-than-1000-patents\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210107005146r1&sid=flmnd&distro=nx&lang=en\",\"datePublished\":\"2021-01-07T13:06:39+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/abiomed-continues-to-strengthen-its-intellectual-property-now-holds-more-than-1000-patents\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/abiomed-continues-to-strengthen-its-intellectual-property-now-holds-more-than-1000-patents\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/abiomed-continues-to-strengthen-its-intellectual-property-now-holds-more-than-1000-patents\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210107005146r1&sid=flmnd&distro=nx&lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210107005146r1&sid=flmnd&distro=nx&lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/abiomed-continues-to-strengthen-its-intellectual-property-now-holds-more-than-1000-patents\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Abiomed Continues to Strengthen its Intellectual Property, Now Holds More Than 1,000 Patents\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Abiomed Continues to Strengthen its Intellectual Property, Now Holds More Than 1,000 Patents - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/abiomed-continues-to-strengthen-its-intellectual-property-now-holds-more-than-1000-patents\/","og_locale":"en_US","og_type":"article","og_title":"Abiomed Continues to Strengthen its Intellectual Property, Now Holds More Than 1,000 Patents - Market Newsdesk","og_description":"Abiomed Continues to Strengthen its Intellectual Property, Now Holds More Than 1,000 Patents DANVERS, Mass.–(BUSINESS WIRE)–Abiomed (NASDAQ: ABMD) announces it has surpassed more than 1,000 patents worldwide, with more than 850 additional patents pending. Abiomed\u2019s robust intellectual property portfolio protects its current and future pump and catheter designs, along with other product components such as motors, cannulas, sensors, software, and access devices. The portfolio also protects manufacturing processes and future artificial intelligence algorithms. Abiomed is recognized as a leader in technology and innovation, with robust clinical data supporting the regulatory approvals and physician adoption of its technologies. The company employs several hundred engineers and scientists at its state-of-the-art research and development facilities in Danvers, Massachusetts, Aachen, Germany, and Berlin, Germany. … Continue reading \"Abiomed Continues to Strengthen its Intellectual Property, Now Holds More Than 1,000 Patents\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/abiomed-continues-to-strengthen-its-intellectual-property-now-holds-more-than-1000-patents\/","og_site_name":"Market Newsdesk","article_published_time":"2021-01-07T13:06:39+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210107005146r1&sid=flmnd&distro=nx&lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/abiomed-continues-to-strengthen-its-intellectual-property-now-holds-more-than-1000-patents\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/abiomed-continues-to-strengthen-its-intellectual-property-now-holds-more-than-1000-patents\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Abiomed Continues to Strengthen its Intellectual Property, Now Holds More Than 1,000 Patents","datePublished":"2021-01-07T13:06:39+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/abiomed-continues-to-strengthen-its-intellectual-property-now-holds-more-than-1000-patents\/"},"wordCount":354,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/abiomed-continues-to-strengthen-its-intellectual-property-now-holds-more-than-1000-patents\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210107005146r1&sid=flmnd&distro=nx&lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/abiomed-continues-to-strengthen-its-intellectual-property-now-holds-more-than-1000-patents\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/abiomed-continues-to-strengthen-its-intellectual-property-now-holds-more-than-1000-patents\/","name":"Abiomed Continues to Strengthen its Intellectual Property, Now Holds More Than 1,000 Patents - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/abiomed-continues-to-strengthen-its-intellectual-property-now-holds-more-than-1000-patents\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/abiomed-continues-to-strengthen-its-intellectual-property-now-holds-more-than-1000-patents\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210107005146r1&sid=flmnd&distro=nx&lang=en","datePublished":"2021-01-07T13:06:39+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/abiomed-continues-to-strengthen-its-intellectual-property-now-holds-more-than-1000-patents\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/abiomed-continues-to-strengthen-its-intellectual-property-now-holds-more-than-1000-patents\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/abiomed-continues-to-strengthen-its-intellectual-property-now-holds-more-than-1000-patents\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210107005146r1&sid=flmnd&distro=nx&lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210107005146r1&sid=flmnd&distro=nx&lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/abiomed-continues-to-strengthen-its-intellectual-property-now-holds-more-than-1000-patents\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Abiomed Continues to Strengthen its Intellectual Property, Now Holds More Than 1,000 Patents"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/410336","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=410336"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/410336\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=410336"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=410336"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=410336"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}